EICHOR
● Active Not Recruiting
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors
Condition: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Sponsor: BeOne Medicines
About this study
The purpose of this study is to investigate the efficacy and safety of BGB-16673 compared with investigator's choice (bendamustine plus rituximab or high-dose methylprednisolone plus rituximab or chlorambucil plus obinutuzumab) in participants with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) previously exposed to covalent Bruton tyrosine kinase inhibitor(s) (cBTKi).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (62)
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | — |
| Peking University Third Hospital | Beijing, Beijing Municipality, China | — |
| Peking University Peoples Hospital | Beijing, Beijing Municipality, China | — |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | — |
| Chongqing University Three Gorges Central Hospital | Chongqing, Chongqing Municipality, China | — |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | — |
| Fujian Medical University Union Hospital | Fuzhou, Fujian, China | — |
| The First Affiliated Hospital of Fujian Medical University | Fuzhou, Fujian, China | — |
| Zhujiang Hospital of Southern Medical University | Guangzhou, Guangdong, China | — |
| Sun Yat Sen University Cancer Center Huangpu Branch | Guangzhou, Guangdong, China | — |
| Meizhou People Hospital | Meizhou, Guangdong, China | — |
| Shenzhen Nanshan Peoples Hospital | Shenzhen, Guangdong, China | — |
+ 50 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06970743